Umbilical spider's web.
Bourseau S, Bastens B, Leclercq P.
Acta Gastroenterol Belg. 2022 Jul-Sep;85(3):542. doi: 10.51821/85.3.10418.
Hemosiderin Hyperpigmentation: Successful Treatment With Q-Switched 755-nm Laser Therapy.
Gan SD, Orringer JS.
Dermatol Surg. 2015 Dec;41(12):1443-4. doi: 10.1097/DSS.0000000000000513.
Pseudomelanosis duodeni.
West B.
J Clin Gastroenterol. 1988 Apr;10(2):127-9.
Cellulite: Clinical Challenges and Future Perspectives.
Shridharani SM, Moradi A, Khalifian S, LaTowsky B, Petraki C, Bass LS.
Dermatol Surg. 2023 Apr 1;49(4S):S15-S20. doi: 10.1097/DSS.0000000000003746. Epub 2023 Mar 9.
Defining diabetic dermopathy.
McCash S, Emanuel PO.
J Dermatol. 2011 Oct;38(10):988-92. doi: 10.1111/j.1346-8138.2011.01251.x. Epub 2011 Jul 18.
Small-bowel pseudomelanosis.
Rodrigues-Pinto E, Cardoso H, Coelho R, Marques M, Andrade P, Dantas N, Macedo G.
Endoscopy. 2015;47 Suppl 1 UCTN:E291-2. doi: 10.1055/s-0034-1391956. Epub 2015 Jun 22.
Revealing the origin of postsclerotherapy hyperpigmentation: Identification of melanin and hemosiderin as causative pigments in a histopathological study.
Bossart S, Ramelet AA, Seyed Jafari SM, Yawalkar N, Feldmeyer L, Heidemeyer K.
Phlebology. 2026 Apr;41(3):217-223. doi: 10.1177/02683555251357095. Epub 2025 Jun 30.
Amitriptyline-induced cutaneous hyperpigmentation: case report and review of psychotropic drug-associated mucocutaneous hyperpigmentation.
Eichenfield DZ, Cohen PR.
Dermatol Online J. 2016 Feb 17;22(2):13030/qt3455571b.
Successful treatment of disfiguring hemosiderin-containing hyperpigmentation with the Q-switched 650-nm wavelength laser.
Hamilton HK, Dover JS, Arndt KA.
JAMA Dermatol. 2014 Nov;150(11):1221-2. doi: 10.1001/jamadermatol.2014.1838.
Postsclerotherapy hyperpigmentation: a histologic evaluation.
Goldman MP, Kaplan RP, Duffy DM.
J Dermatol Surg Oncol. 1987 May;13(5):547-50. doi: 10.1111/j.1524-4725.1987.tb00940.x.
